The Host Cell Protein Testing Market is experiencing transformative growth driven by the urgent need to address immunogenicity risks associated with residual host cell proteins in increasingly complex biologic therapeutics. As the industry develops next-generation modalities including multispecific antibodies, mRNA vaccines, and cell therapies manufactured in diverse expression systems, the...